	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	C 2015 Mar 31	R 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	522	607	678	714	755	766	748	788	831	613	888	1,099	1,245	1,356	1,483
Cost of Operating Revenue	276	327	354	364	379	375	362	373	387	283	420	515	571	633	689
Gross Profit	245	280	324	350	377	390	386	415	444	330	469	583	673	723	793
Gross Margin	47.1	46.1	47.7	49.0	49.9	51.0	51.6	52.6	53.4	53.9	52.8	53.1	54.1	53.3	53.5
Total Operating Expenses	477	554	615	658	710	717	706	736	776	606	803	986	1,090	1,156	1,259
Operating Profit	45	53	63	57	45	49	43	52	54	8	85	112	154	200	223
Operating Margin	8.6	8.7	9.3	7.9	6.0	6.4	5.7	6.7	6.6	1.2	9.6	10.2	12.4	14.8	15.1
Financing Income/(Expense) - Net	-6	-8	-9	-8	-7	-8	-8	-6	-6	-3	-3	6	13	16	-6
Profit before Taxes	40	45	54	50	39	41	34	45	48	4	79	117	166	216	246
Income Taxes	13	17	19	17	14	15	13	16	5	2	20	31	42	55	62
Profit after Tax	27	29	35	32	24	26	21	28	44	2	59	86	124	161	184
PAT Margin	5.2	4.7	5.2	4.5	3.2	3.4	2.8	3.6	5.3	0.4	6.6	7.8	10.0	11.9	12.4
EPS - Basic - ex Extraordinary Items	2.94	3.14	3.87	3.54	2.67	2.86	2.30	3.10	4.76	0.25	6.39	9.40	13.52	17.56	20.03
EPS - Diluted - ex Extraordinary Items	2.94	3.14	3.87	3.54	2.67	2.86	2.30	3.10	4.76	0.25	6.39	9.40	13.52	17.56	20.03
EBIT	45	53	63	57	45	49	43	52	54	8	85	112	154	200	223
EBITDA	67	79	91	85	80	79	73	82	87	41	120	152	195	245	267
EBITDA Margin	12.8	12.9	13.4	11.9	10.6	10.4	9.8	10.4	10.5	6.7	13.5	13.8	15.6	18.0	18.0

Balance Sheet

Abridged

Understanding Balance Sheet

Indraprastha Medical Corporation Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	2013 Mar 31	C 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	119.44	132.00	147.26	128.60	152.18	157.94	132.90	135.55	141.47	141.43	157.43	223.08	307.98	431.13	416.59
Long-Term Investments	6.06	5.61	6.70	-	-	-	0.01	0.04	-	-	23.01	45.51	60.52	54.92	203.50
Property Plant & Equipment - Net	275.25	299.72	292.41	304.67	301.77	293.89	292.77	280.92	301.27	283.29	275.15	276.62	346.36	359.99	367.27
Total Non-Current Assets	282.55	306.12	301.54	311.10	308.31	300.50	299.37	286.81	307.52	290.53	304.28	332.06	415.26	420.49	574.77
Total Assets	401.99	438.13	448.80	439.71	460.50	458.44	432.27	422.37	448.99	431.96	461.71	555.14	723.24	851.62	991.36
Total Current Liabilities	176.26	196.16	191.98	165.53	190.52	185.74	138.43	124.09	139.60	115.91	93.50	129.63	165.42	178.71	169.55
Long Term Debt	27.88	29.71	25.83	10.72	2.50	-	21.00	15.00	-	-	2.48	-	32.27	30.54	33.18
Total Non-Current Liabilities	66.46	70.98	69.70	54.77	46.23	41.87	61.53	54.24	41.59	43.29	42.77	46.06	80.06	76.23	81.44
Total Liabilities	242.72	267.14	261.68	220.31	236.75	227.62	199.96	178.33	181.19	159.20	136.27	175.69	245.48	254.94	250.99
Total Shareholders' Equity	159.27	170.99	187.12	219.40	223.75	230.83	232.31	244.04	267.80	272.76	325.44	379.45	477.76	596.68	740.37
Total Equity	159.27	170.99	187.12	219.40	223.75	230.83	232.31	244.04	267.80	272.76	325.44	379.45	477.76	596.68	740.37
Total Liabilities & Equity	401.99	438.13	448.80	439.71	460.50	458.44	432.27	422.37	448.99	431.96	461.71	555.14	723.24	851.62	991.36

Cash Flow

Abridged

Understanding Cash Flow Statement

Indraprastha Medical Corporation Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	48.96	63.83	65.52	59.12	53.60	54.41	53.23	60.22	69.64	29.08	99.63	146.38	155.95	194.70	219.34
Working Capital - Increase/(Decrease)	4.20	-0.53	-12.85	1.62	6.89	-26.83	-6.64	13.29	15.50	-1.19	-26.46	6.66	55.46	-23.80	-29.99
Net CF from Operating Activities	53.16	63.30	52.67	60.74	60.49	27.58	46.59	73.51	85.14	27.89	73.17	153.04	211.41	170.90	189.35
Capital Expenditures - Net	28.21	54.54	22.01	29.53	32.94	22.91	30.69	17.09	40.92	20.96	29.48	44.58	69.39	36.33	59.65
Net CF from Investing Activities	-28.21	-54.54	-22.01	-29.53	-32.94	-22.91	-30.69	-17.09	-40.92	-20.96	-53.58	-116.85	-170.74	-128.16	-202.44
Dividends Paid - Cash - Total	16.95	16.96	17.08	19.27	19.79	19.82	19.82	16.11	17.86	0.25	0.26	22.84	27.54	40.73	41.03
Debt - LT & ST - Issuance/(Retirement) - Total	-7.32	8.50	-13.38	-12.00	-8.22	15.00	4.50	-26.00	-22.85	-2.09	-2.51	-2.83	-3.79	-2.13	-2.43
Net Cash Flow from Financing Activities	-24.28	-8.46	-30.45	-31.27	-28.01	-4.82	-15.32	-42.11	-40.71	-2.34	-2.77	-25.67	-31.33	-42.86	-43.46
Free Cash Flow to Equity	17.63	17.25	17.29	19.21	19.33	19.67	20.40	30.42	21.38	4.83	41.18	105.63	138.23	132.44	127.27
Free Operating CF net dividend	8.00	-8.20	13.59	11.94	7.76	-15.15	-3.92	40.30	26.36	6.68	43.43	85.62	114.48	93.84	88.67
Free Operating CF	24.95	8.75	30.67	31.21	27.55	4.67	15.90	56.42	44.23	6.93	43.69	108.46	142.02	134.57	129.70

Business Segment Analysis

FY End:

Mar 25

Indraprastha Medical Corporation Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

HealthCare (100.0%)₹ 36.33 Cr

Revenue / Sales

HealthCare (100.0%)₹ 1,356.36 Cr

Assets

HealthCare (100.0%)₹ 851.62 Cr

Operating Income

HealthCare (100.0%)₹ 200.46 Cr

Regional Segment Analysis

Indraprastha Medical Corporation Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Indraprastha Medical Corporation Ltd.

Historical Segment Analysis

Track how Indraprastha Medical Corporation Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

HealthCare	21	29	45	69	36

Frequently Asked Questions

What is the revenue of Indraprastha Medical Corporation Ltd.?

The latest trailing twelve month revenue of Indraprastha Medical Corporation Ltd. is ₹ 1,482.51 Cr, reflecting a 1-year growth of 9.30% and a 3-year CAGR of 10.50%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Indraprastha Medical Corporation Ltd.?

The latest trailing twelve month net profit (PAT) of Indraprastha Medical Corporation Ltd. is ₹ 183.62 Cr, with a 3-year earnings CAGR of 28.69%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Indraprastha Medical Corporation Ltd.?

The trailing twelve month EBITDA of Indraprastha Medical Corporation Ltd. is approximately ₹ 223.29 Cr (based on an operating margin of 15.06%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Indraprastha Medical Corporation Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Indraprastha Medical Corporation Ltd. is 20.03. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Indraprastha Medical Corporation Ltd.?

The debt-to-equity ratio of Indraprastha Medical Corporation Ltd. stands at 0.05. The interest coverage ratio is 37.09x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Indraprastha Medical Corporation Ltd.?

The estimated book value per share of Indraprastha Medical Corporation Ltd. is 81.73 (derived from a P/B ratio of 4.51 and market price of ₹ 368.95), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Indraprastha Medical Corporation Ltd.?

The trailing twelve month operating cash flow of Indraprastha Medical Corporation Ltd. is ₹ 189.35 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Indraprastha Medical Corporation Ltd. report consolidated or standalone financials?

Indraprastha Medical Corporation Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.